Inventor
Shelley R. Winn
Inventor
Smithfield, RI, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
C12NMicroorganisms or enzymes22%
C07KPeptides16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
A61LMethods or apparatus for sterilising materials or objects in general10%
A61FFilters implantable into blood vessels7%
A61MDevices for introducing media into, or onto, the body5%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry5%
B01DSeparation1%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
PatentTitleYear
6,264,941'Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules'20015,935,849'Methods and compositions of growth control for cells encapsulated within bioartificial organs'19995,908,623'Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules'19995,858,747'Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers'19995,853,717'Methods and compositions of growth control for cells encapsulated within bioartificial organs'19985,843,431'Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation'19985,840,576'Methods and compositions of growth control for cells encapsulated within bioartificial organs'19985,837,234'Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane'19985,833,979'Methods and compositions of growth control for cells encapsulated within bioartificial organs'19985,795,790'Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs'19985,776,747'Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer'1998RE035653'In vivo delivery of neurotransmitters by implanted, encapsulated cells'19975,676,943'Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules'19975,656,481'Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules'19975,653,975'Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules'19975,639,275'Delivery of biologically active molecules using cells contained in biocompatible immunoisolatory capsules'19975,182,111'In vivo delivery of active factors by co-cultured cell implants'19935,156,844'Neurological therapy system'19925,106,627'Neurological therapy devices'19924,892,538'In vivo delivery of neurotransmitters by implanted, encapsulated cells'1990Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1990–1997Patents assigned to UNIV BROWN RES FOUND (5)· patent assignee history
1990–1997Based in Providence, RI, US· patent location history
1997–1999Patents assigned to CYTOTHERAPEUTICS INC (13)· patent assignee history
1997Patents assigned to CYTO THERAPEUTICS INC (1)· patent assignee history
1997–2001Based in Smithfield, RI, US· patent location history
2001Patents assigned to NEUROTECH SA (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CYTOTHERAPEUTICS INC | 13 | 1997–1999 |
| UNIV BROWN RES FOUND | 5 | 1990–1997 |
| CYTO THERAPEUTICS INC | 1 | 1997 |
| NEUROTECH SA | 1 | 2001 |
Locations
| Location | Patents | Span |
|---|---|---|
| Smithfield, RI, US | 15 | 1997–2001 |
| Providence, RI, US | 5 | 1990–1997 |